#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Transplant rejection Primary mediastinal large B-cell lymphoma Ventricular tachycardia Hyperoxaluria Immunoglobulin G4 related disease Erdheim-Chester disease Pyruvate dehydrogenase complex deficiency Glomerulonephritis chronic Plasma cell myeloma Pneumonia Cardiac arrest Dilated cardiomyopathy Fabry's disease Atopic keratoconjunctivitis Small cell lung cancer limited stage More trials…

    Learn about Rare Diseases

    Loeys-Dietz syndrome Nephrotic syndrome Haemolytic uraemic syndrome – Trials in Disease Haemophilia A with anti factor VIII – Diagnostics Haemophilia A without inhibitors – Trials in Disease Gaucher’s disease type III – Diagnostics Extranodal marginal zone B-cell lymphoma (MALT type) – Treatment Pemphigoid – Diagnostics Hereditary hypophosphataemic rickets Osteosarcoma recurrent – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Guanfacine M1P Dipotassium Salt Nedosiran Apixaban Darunavir Cefotaxime Sodium Sitagliptin Lorlatinib Dyp688 Pyridoxine Mva-209-Fsp-B4 Xaluritamig LY3841136 SODIUM LIPASE Alkaline Phosphatase, Bovine Azd5004 Anifrolumab Terbinafine Hydrochloride Nofazinlimab Etrumadenant More therapies…

    Learn about Your Condition

    Medication overuse headache Cystic fibrosis lung Eclampsia Myasthenia gravis Iron overload Type 2 diabetes mellitus Post cardiac arrest syndrome Urticaria Endotracheal intubation Thromboangiitis obliterans Vulvovaginal dryness Eructation KBG syndrome Fibrosarcoma HIV infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nervous System Diseases

  • Study of Lutetium (177Lu) Oxodotreotide for Children with Relapsed or Refractory High-Risk Neuroblastoma

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Edotreotide
    • L-Arginine Hydrochloride
    • L-Lysine Hydrochloride
    Denmark Lithuania The Netherlands Norway Spain Sweden

  • Study on the Effects of Azetukalner in Patients with Focal-Onset Seizures

    Recruiting

    3 1
    Investigated Diseases:
    • Partial seizures
    Investigated Drugs:
    • Azetukalner
    Austria Belgium Bulgaria Croatia Czechia Finland +8

  • Study on the Effects of Rituximab for Patients with Amyotrophic Lateral Sclerosis (ALS)

    Recruiting

    2 1 1
    Investigated Diseases:
    • Amyotrophic lateral sclerosis
    Investigated Drugs:
    • Methylprednisolone Hydrogen Succinate
    • Paracetamol
    • Rituximab
    Germany

  • Study on Pain in Parkinson’s Disease: Examining the Effects of 18F-MPPF in Patients with and without Pain

    Recruiting

    2 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • 4-Fluoro-N-[2-[4-(2-Methoxyphenyl)Piperazin-1-Yl]Ethyl]-N-Pyridin-2-Ylbenzamide
    France

  • Study on Fremanezumab for Pain Relief in Patients with Complex Regional Pain Syndrome

    Recruiting

    2 1 1
    Investigated Diseases:
    • Complex regional pain syndrome
    Investigated Drugs:
    • Fremanezumab
    Denmark

  • Study on the Effects of XEN1101 and Placebo for Patients with Primary Generalized Tonic-Clonic Seizures

    Recruiting

    3 1
    Investigated Diseases:
    • Generalised tonic-clonic seizure
    Investigated Drugs:
    • Azetukalner
    Austria Belgium Bulgaria Croatia Czechia France +6
Previous Page
1 … 50 51 52 53 54 … 141
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!